BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 12629372)

  • 1. A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis.
    Nickel JC; Pontari M; Moon T; Gittelman M; Malek G; Farrington J; Pearson J; Krupa D; Bach M; Drisko J;
    J Urol; 2003 Apr; 169(4):1401-5. PubMed ID: 12629372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial.
    Nickel JC; Narayan P; McKay J; Doyle C
    J Urol; 2004 Apr; 171(4):1594-7. PubMed ID: 15017228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study.
    Nickel JC; Forrest JB; Tomera K; Hernandez-Graulau J; Moon TD; Schaeffer AJ; Krieger JN; Zeitlin SI; Evans RJ; Lama DJ; Neal DE; Sant GR
    J Urol; 2005 Apr; 173(4):1252-5. PubMed ID: 15758763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial.
    Cheah PY; Liong ML; Yuen KH; Teh CL; Khor T; Yang JR; Yap HW; Krieger JN
    J Urol; 2003 Feb; 169(2):592-6. PubMed ID: 12544314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis).
    Nickel JC; Downey J; Pontari MA; Shoskes DA; Zeitlin SI
    BJU Int; 2004 May; 93(7):991-5. PubMed ID: 15142149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of rofecoxib in patients with chronic low back pain: results from two 4-week, randomized, placebo-controlled, parallel-group, double-blind trials.
    Katz N; Ju WD; Krupa DA; Sperling RS; Bozalis Rodgers D; Gertz BJ; Gimbel J; Coleman S; Fisher C; Nabizadeh S; Borenstein D;
    Spine (Phila Pa 1976); 2003 May; 28(9):851-8; discussion 859. PubMed ID: 12941996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study.
    Wagenlehner FM; Schneider H; Ludwig M; Schnitker J; Brähler E; Weidner W
    Eur Urol; 2009 Sep; 56(3):544-51. PubMed ID: 19524353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rofecoxib 50 mg and valdecoxib 20 or 40 mg in adults and adolescents with postoperative pain after third molar extraction: results of two randomized, double-blind, placebo-controlled, single-dose studies.
    Daniels SE; Desjardins PJ; Bird SR; Smugar SS; Tershakovec AM
    Clin Ther; 2006 Jul; 28(7):1022-34. PubMed ID: 16990080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective, randomized, double-blind trial to evaluate the role of a short reducing course of oral corticosteroid therapy in the treatment of chronic prostatitis/chronic pelvic pain syndrome.
    Bates SM; Hill VA; Anderson JB; Chapple CR; Spence R; Ryan C; Talbot MD
    BJU Int; 2007 Feb; 99(2):355-9. PubMed ID: 17313424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analgesic efficacy of the cyclooxygenase-inhibiting nitric oxide donor AZD3582 in postoperative dental pain: Comparison with naproxen and rofecoxib in two randomized, double-blind, placebo-controlled studies.
    Michael Hill C; Sindet-Pederson S; Seymour RA; Hawkesford JE; Coulthard P; Lamey PJ; Gerry Cowan C; Wickens M; Jeppsson L; Dean AD; Svensson O
    Clin Ther; 2006 Sep; 28(9):1279-95. PubMed ID: 17062301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of patient response to antibiotic therapy for the chronic prostatitis/chronic pelvic pain syndrome: a prospective multicenter clinical trial.
    Nickel JC; Downey J; Johnston B; Clark J;
    J Urol; 2001 May; 165(5):1539-44. PubMed ID: 11342913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of chronic prostatitis/chronic pelvic pain syndrome category IIIA with Serenoa repens plus selenium and lycopene (Profluss) versus S. repens alone: an Italian randomized multicenter-controlled study.
    Morgia G; Mucciardi G; Galì A; Madonia M; Marchese F; Di Benedetto A; Romano G; Bonvissuto G; Castelli T; Macchione L; Magno C
    Urol Int; 2010; 84(4):400-6. PubMed ID: 20332612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of rofecoxib 50 mg and hydrocodone/acetaminophen 7.5/750 mg in patients with post-arthroscopic pain.
    Chelly JE; Nissen CW; Rodgers AJ; Smugar SS; Tershakovec AM
    Curr Med Res Opin; 2007 Jan; 23(1):195-206. PubMed ID: 17207303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three-arm randomized trial.
    Lee SH; Lee BC
    Urology; 2009 May; 73(5):1036-41. PubMed ID: 19394499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of a monotherapy strategy for difficult chronic prostatitis/chronic pelvic pain syndrome.
    Nickel JC; Downey J; Ardern D; Clark J; Nickel K
    J Urol; 2004 Aug; 172(2):551-4. PubMed ID: 15247727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT.
    Shoskes DA; Nickel JC; Kattan MW
    Urology; 2010 Jun; 75(6):1249-53. PubMed ID: 20363491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of Huafenqinutang and vardenafil for treatment of chronic prostatitis/chronic pelvic pain syndrome with concomitant erectile dysfunction].
    Lin ZF; Chen BT; Zeng K; Lan HM; Wun J
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):532-4. PubMed ID: 17545052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of rofecoxib 12.5 mg and celecoxib 200 mg in two similarly designed osteoarthritis studies.
    Birbara C; Ruoff G; Sheldon E; Valenzuela C; Rodgers A; Petruschke RA; Chang DJ; Tershakovec AM
    Curr Med Res Opin; 2006 Jan; 22(1):199-210. PubMed ID: 16393445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silodosin for men with chronic prostatitis/chronic pelvic pain syndrome: results of a phase II multicenter, double-blind, placebo controlled study.
    Nickel JC; O'Leary MP; Lepor H; Caramelli KE; Thomas H; Hill LA; Hoel GE
    J Urol; 2011 Jul; 186(1):125-31. PubMed ID: 21571345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.